These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35856818)

  • 21. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 22. Reducing treatment burden in the era of CFTR modulators.
    Robinson PD; Douglas TA; Wainwright CE
    Lancet Respir Med; 2023 Sep; 11(9):e78. PubMed ID: 37321239
    [No Abstract]   [Full Text] [Related]  

  • 23. New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.
    Ong T; Ramsey BW
    Pediatr Clin North Am; 2016 Aug; 63(4):751-64. PubMed ID: 27469186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.
    Fohner AE; McDonagh EM; Clancy JP; Whirl Carrillo M; Altman RB; Klein TE
    Pharmacogenet Genomics; 2017 Jan; 27(1):39-42. PubMed ID: 27636560
    [No Abstract]   [Full Text] [Related]  

  • 25. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
    Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
    [No Abstract]   [Full Text] [Related]  

  • 26. A combination therapy for cystic fibrosis.
    Brodsky JL; Frizzell RA
    Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing.
    Hoppe JE; Zemanick ET; Martiniano SL
    Am J Respir Crit Care Med; 2022 Dec; 206(11):1308-1310. PubMed ID: 35947636
    [No Abstract]   [Full Text] [Related]  

  • 28. Promising new era dawns for cystic fibrosis treatment.
    Corbyn Z
    Lancet; 2012 Apr; 379(9825):1475-6. PubMed ID: 22530244
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination CFTR modulator therapy in children and adults with cystic fibrosis.
    Guimbellot JS; Taylor-Cousar JL
    Lancet Respir Med; 2021 Jul; 9(7):677-679. PubMed ID: 33965001
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonology: CFTR modulators for cystic fibrosis.
    Bertoncini E; Colomb-Lippa D
    JAAPA; 2013 Feb; 26(2):59-60. PubMed ID: 23409389
    [No Abstract]   [Full Text] [Related]  

  • 31. Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis.
    McCarthy C; Brewington JJ; Harkness B; Clancy JP; Trapnell BC
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29563174
    [No Abstract]   [Full Text] [Related]  

  • 32. [Causal therapy is available].
    Meißner T
    MMW Fortschr Med; 2016 Jun; 158(12):74. PubMed ID: 27324018
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy for cystic fibrosis--the end of the beginning?
    Davis PB
    N Engl J Med; 2011 Nov; 365(18):1734-5. PubMed ID: 22047565
    [No Abstract]   [Full Text] [Related]  

  • 34. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
    Yang H; Ma T
    Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Future of Highly Effective Modulator Therapy in Cystic Fibrosis.
    Daines CL; Morgan WJ
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1453-1455. PubMed ID: 33901406
    [No Abstract]   [Full Text] [Related]  

  • 36. New Drug Hailed as Major Breakthrough in Cystic Fibrosis.
    Am J Med Genet A; 2020 Jan; 182(1):8-9. PubMed ID: 31825178
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutation-specific cystic fibrosis treatments on verge of approval.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):396-7. PubMed ID: 21475213
    [No Abstract]   [Full Text] [Related]  

  • 38. Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?
    Jones AM; Barry PJ
    Thorax; 2015 Jul; 70(7):615-6. PubMed ID: 26071414
    [No Abstract]   [Full Text] [Related]  

  • 39. PharmGKB summary: very important pharmacogene information for CFTR.
    McDonagh EM; Clancy JP; Altman RB; Klein TE
    Pharmacogenet Genomics; 2015 Mar; 25(3):149-56. PubMed ID: 25514096
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.